Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Artivion, Inc. Common Stock
(NY:
AORT
)
23.52
+0.03 (+0.11%)
Streaming Delayed Price
Updated: 3:35 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Artivion, Inc. Common Stock
< Previous
1
2
Next >
ICU Medical (ICUI) Q4 Earnings Report Preview: What To Look For
February 26, 2025
Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results tomorrow after market close. Here’s what you need to know.
Via
StockStory
Artivion (AORT) Stock Trades Down, Here Is Why
February 25, 2025
Shares of medical device company Artivion (NYSE:AORT) fell 11.2% in the morning session after the company reported weak fourth-quarter 2024 results, as both revenue and EPS missed Wall Street's...
Via
StockStory
Breaking Down Artivion: 4 Analysts Share Their Views
February 25, 2025
Via
Benzinga
Artivion (NYSE:AORT) Misses Q4 Sales Targets
February 24, 2025
Medical device company Artivion (NYSE:AORT) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 3.9% year on year to $97.31 million. The company’s full-year revenue guidance of $427.5...
Via
StockStory
Artivion (AORT) Q4 Earnings: What To Expect
February 23, 2025
Medical device company Artivion (NYSE:AORT) will be reporting results tomorrow after the bell. Here’s what you need to know.
Via
StockStory
Where Artivion Stands With Analysts
January 28, 2025
Via
Benzinga
In-Depth Examination Of 6 Analyst Recommendations For Artivion
December 10, 2024
Via
Benzinga
Where Artivion Stands With Analysts
November 08, 2024
Via
Benzinga
Earnings Scheduled For February 24, 2025
February 24, 2025
Via
Benzinga
Assessing Artivion: Insights From 6 Financial Analysts
October 23, 2024
Via
Benzinga
The Latest Analyst Ratings For Artivion
October 23, 2024
Via
Benzinga
Analyst Scoreboard: 5 Ratings For Artivion
September 13, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Artivion Through 4 Analysts
July 02, 2024
Via
Benzinga
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
February 14, 2025
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers.
Via
StockStory
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
February 14, 2025
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including...
Via
StockStory
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
February 13, 2025
Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers.
Via
StockStory
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
February 13, 2025
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Merit Medical Systems...
Via
StockStory
Breaking Down Artivion: 4 Analysts Share Their Views
May 07, 2024
Via
Benzinga
Earnings Scheduled For February 15, 2024
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
Artivion's Earnings: A Preview
February 14, 2024
Via
Benzinga
AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
AORT stock results show that Artivion beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
3 Earnings All-Stars With More Room to Run
July 03, 2024
Travelers, Seagate Technology and Artivion are top earnings outperformers poised for further growth and significant returns.
Via
InvestorPlace
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 07, 2024
Via
Benzinga
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
May 07, 2024
Via
Benzinga
AORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
AORT stock results show that Artivion beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 19, 2024
Via
Benzinga
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
February 16, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 16, 2024
Shares of DoorDash, Inc. (NASDAQ: DASH) fell sharply in today’s session as the company reported mixed financial results for its fourth quarter.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Via
Benzinga
'Most Suspicious Congressional Stock Trade?' Little-Known Med Tech Firm Surges 48% In Just 2 Months After Senator Tina Smith Bought The Dip
December 28, 2023
Sen. Tina Smith's (D-Minn.) controversial November investment yielded a 48% return within just two months.
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.